tci Part B Insider - 2003 Issue 17

Want To Put In Your Two Cents On Eye Therapy? Here's Your Chance

If your physician uses ocular photodynamic therapy with verteporfin for patients with eye problems, you should encourage him or her to stand up for Medicare reimbursement for this service.    The Medicare Coverage Advisory Committee will meet on Sept. 9, according to a notice in the July 25 Federal Register (Vol. 68, No. 143). The committee will consider OPT with verteporfin for Medicare patients with age-related macular degeneration and occult without any classic choroidal neovascularization. You have until Aug. 21 to submit presentations by e-mailing matkinson@cms.hhs.gov or phoning (410) 786-2881. ...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.